HOULIHAN LOKEY, INC.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $HLI in the last 30 days.
See all $HLI insider activity →Goldman Sachs and Houlihan Lokey led consumer-sector M&A in Q1–Q3 2026. Goldman advised on $57.14bn deals, up 428.2% YoY, boosted by Unilever's $44.8bn foods business deal with McCormick. Houlihan led in volume with 19 deals. Citi, Morgan Stanley, Rothschild & Co., and Bank of America also ranked high in value or volume.
Houlihan Lokey (HLI) will report Q3 earnings, with analysts expecting a 3.7% revenue decline year on year. Last quarter, the company missed revenue, EBITDA, and EPS estimates. Peers Goldman Sachs and Jefferies reported revenue growth, but their shares fell. HLI's average price target is $155.44, with shares up 1.3% in the last month.
Goldman Sachs led North American M&A advisers by deal value ($510.5bn) in Q1–Q3 2026, while Houlihan Lokey topped by deal volume (161). JPMorgan, Morgan Stanley, Bank of America, and Wells Fargo followed in value rankings. Morgan Stanley, JPMorgan, and Goldman Sachs ranked high in volume. Goldman Sachs saw a 42.1% year-on-year value increase, advising on 17 mega deals (>$10bn).
Over the past 7 days, AlphAI's AI scored 5 news stories mentioning HLI (HOULIHAN LOKEY, INC.). Coverage has skewed bullish: 3 bullish, 1 neutral, and 1 bearish.
Recent HLI coverage spans financial news, earnings and sector analysis.
Volume leadership reinforces Houlihan Lokey's market position in consumer deals.
The revenue miss suggests downward pressure on the stock ahead of the earnings release.
Neutral impact; volume leadership is a positive signal but not a price driver.
Volume leadership may enhance Houlihan Lokey's deal flow outlook.
Potential modest upside as volume leader.
AlphAI scores every news story that mentions HLI with an AI model for sentiment and relevance, and aggregates insider trades from HOULIHAN LOKEY, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Goldman Sachs and Houlihan Lokey led consumer-sector M&A in Q1–Q3 2026. Goldman advised on $57.14bn deals, up 428.2% YoY, boosted by Unilever's $44.8bn foods business deal with McCormick. Houlihan led in volume with 19 deals. Citi, Morgan Stanley, Rothschild & Co., and Bank of America also ranked high in value or volume.
2 min readHoulihan Lokey (HLI) will report Q3 earnings, with analysts expecting a 3.7% revenue decline year on year. Last quarter, the company missed revenue, EBITDA, and EPS estimates. Peers Goldman Sachs and Jefferies reported revenue growth, but their shares fell. HLI's average price target is $155.44, with shares up 1.3% in the last month.
1 min readGoldman Sachs led North American M&A advisers by deal value ($510.5bn) in Q1–Q3 2026, while Houlihan Lokey topped by deal volume (161). JPMorgan, Morgan Stanley, Bank of America, and Wells Fargo followed in value rankings. Morgan Stanley, JPMorgan, and Goldman Sachs ranked high in volume. Goldman Sachs saw a 42.1% year-on-year value increase, advising on 17 mega deals (>$10bn).
2 min readGlobalData ranked top M&A advisers in North America for Q1-Q3 2026. Goldman Sachs led by value ($510.5B), Houlihan Lokey by volume (161 deals). JPMorgan, Morgan Stanley, Bank of America, and Wells Fargo followed. Kirkland & Ellis topped legal advisers by value and volume.
2 min readGoldman Sachs led in M&A value with $687.6B in transactions for 2026's first nine months, up 52.3% YoY. Morgan Stanley and JPMorgan ranked second and third with $659.9B and $492.5B, respectively. Houlihan Lokey led in deal count with 250 transactions.
2 min readGoldman Sachs (GS) led in M&A advisory value with $687.6B in deals, while Houlihan Lokey (HLI) topped in volume with 250 deals, according to GlobalData's Q1-Q3 rankings. The list includes transactions valued at $1B or more.
1 min readCitizens upgraded Houlihan Lokey (HLI) to Market Outperform, citing earnings potential, and set a $175 price target. Shares rose 1.90% to $127.92 during morning trading on Friday.
1 min readHoulihan Lokey's average stock price target was reduced by analysts from $154.12 to $152.62, with a range of $147 to $165. This implies a 22% upside from the Oct. 7 closing price. The consensus rating remains 'Buy' among 11 analysts.
1 min readUBS raised its price target for Houlihan Lokey to $154 from $147, maintaining a neutral rating. The company's stock is currently trading at $123.40, down 3.54% over five days but up 0.38% year-to-date. Recent developments include a new office opening and a new managing director appointment.
1 min readGoldman Sachs (GS) reported $20.34B revenue, up 39.5% YoY, beating estimates. Houlihan Lokey (HLI) reported $511M revenue, down 15.6% YoY, missing estimates. PJT (PJT) reported $486.3M revenue, up 19.5% YoY, beating estimates. Perella Weinberg (PWP) reported $156.5M revenue, flat YoY, topping estimates. Stocks reacted accordingly post-earnings.
2 min read
